1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
(
- Contribution to journal › Article
- 2021
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
(
- Contribution to journal › Letter
- 2019
-
Mark
Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'
(
- Contribution to journal › Article
-
Mark
Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma
(
- Contribution to journal › Article
- 2018
-
Mark
Reduction in White Blood Cell, Neutrophil, and Red Blood Cell Counts Related to Sex, HLA, and Islet Autoantibodies in Swedish TEDDY Children at Increased Risk for Type 1 Diabetes
(
- Contribution to journal › Article
- 2017
-
Mark
Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls
(
- Contribution to journal › Article
- 2015
-
Mark
Tapasin is a key component to understand immunogenicity in glioblastoma
(
- Contribution to conference › Poster
-
Mark
HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma
(
- Contribution to journal › Article
-
Mark
Transglutaminase 4 as a prostate autoantigen in male subfertility.
(
- Contribution to journal › Article